Current evidence indicates that extracellular aggregation of α-synuclein may be implicated in the pathogenesis of Parkinson’s disease and that KLK6 mediates its degradation directly and via a proteolytic cascade that involves MMPs (Pampalakis et al., 2017). This evidence concerns the gene KLK6 and Parkinson disease.